ClinicalTrials.gg
CompletedNCT06107543Updated Jun 25, 2024

Lidocaine in the Prevention of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation

An observational study in Lidocaine, sponsored by Derince Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-06-25.

Sponsored by Derince Training and Research Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
94
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Direct laryngoscopy and endotracheal intubation procedure stimulate the sympathetic nervous system, causing catecholamine release into the circulation and consequently hemodynamic changes.There are many studies showing that lidocaine is used intravenously to suppress the sympathetic response to laryngoscopy and endotracheal intubation. Nebulized lidocaine is often used to provide upper airway local anesthesia in fiberoptic guided awake intubation.

In this study, the researchers aimed to compare the results of using intravenous lidocaine and nebulized lidocaine to suppress the hemodynamic response caused by laryngoscopy and endotracheal intubation retrospectively.

Researchers' hypothesis; Nebulized lidocaine administration is more effective than intravenous lidocaine administration in suppressing the hemodynamic response due to laryngoscopy and endotracheal intubation in patients under general anesthesia.

Read the detailed description

2% lidocaine drug to suppress the hemodynamic response due to laryngoscopy and endotracheal intubation; patients administered intravenously will be evaluated in one group, and patients administered inhaled through a nebulizer will be evaluated in another group.

Nebulized lidocaine in the researchers' clinic; it is administered by adding 2% lidocaine + physiological saline to a nebulizer and inhaling for 3-5 minutes in the presence of 4-6 liters/minute of oxygen.

Preoperative examination forms and intraoperative follow-up forms of the patients included in the study will be examined by the researchers. The dose of lidocaine applied and the method of administration will be recorded. In addition, the agents used in anesthesia induction (fentanyl, propofol, rocuronium bromide, etc.) and the hemodynamic changes of the patients (heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure,oxygen saturation) will be recorded.

02

Conditions studied

  • Lidocaine

Keywords

  • Lidocaine
  • Intubation
  • General anaesthesia
03

In context

Lead sponsor

Derince Training and Research Hospital is the lead sponsor of 39 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

80 patients over the age of 18 and under the age of 80 who underwent surgery under general anesthesia in the operating room will be included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over the age of 18 and under the age of 80 who underwent surgery under general anesthesia

Exclusion criteria

Exclusion Criteria:

  • Patients under the age of 18 and over the age of 80
  • Patients who are not operated under general anesthesia
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
94 participants (actual)
Patient registry
No

Groups and cohorts

  • Intravenous lidocaine

    Patients who received lidocaine intravenously before induction of anesthesia will be considered in this group.

    Drug: Iv Lidocaine

  • Nebulized lidocaine

    Patients who received lidocaine by inhalation with a nebulizer before induction of anesthesia will be considered in this group.

    Drug: Nebulized Lidocaine

Interventions

  • DrugLidocaineStudies of LidocaineLidocaine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Before induction of anesthesia, 2% lidocaine + physiological saline was added to a nebulizer and inhaled for 3-5 minutes in the presence of 4-6 liters/minute of oxygen.

  • DrugLidocaineStudies of LidocaineLidocaine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Intravenous %2 lidocaine was administered before induction of anesthesia.

06

What researchers measure

Primary outcomes

  1. Heart Rate

    Patients were monitored with a three-lead ECG in the operating room and their heart rates were recorded as beats per minute. (.../min)

    Time frame: Just before induction of anesthesia

  2. Heart Rate

    Patients were monitored with a three-lead ECG in the operating room and their heart rates were recorded as beats per minute. (.../min)

    Time frame: Immediately after induction of anesthesia

  3. Heart Rate

    Patients were monitored with a three-lead ECG in the operating room and their heart rates were recorded as beats per minute. (.../min)

    Time frame: 5 minutes and 10 minutes after direct laryngoscopy and endotracheal intubation

  4. Blood Pressure

    The patients were monitored in the operating room by wearing a noninvasive blood pressure cuff and measurements were taken at 5-minute intervals. Systolic blood pressure, diastolic blood pressure and mean arterial pressure were recorded in mmHg.

    Time frame: Just before induction of anesthesia

  5. Blood Pressure

    The patients were monitored in the operating room by wearing a noninvasive blood pressure cuff and measurements were taken at 5-minute intervals. Systolic blood pressure, diastolic blood pressure and mean arterial pressure were recorded in mmHg.

    Time frame: Immediately after induction of anesthesia

  6. Blood Pressure

    The patients were monitored in the operating room by wearing a noninvasive blood pressure cuff and measurements were taken at 5-minute intervals. Systolic blood pressure, diastolic blood pressure and mean arterial pressure were recorded in mmHg.

    Time frame: 5 minutes and 10 minutes after direct laryngoscopy and endotracheal intubation

  7. Oxygen Saturation

    The patients were monitored with a pulse oximetry device in the operating room and their oxygen saturation % (spO2) was recorded.

    Time frame: Just before induction of anesthesia

  8. Oxygen Saturation

    The patients were monitored with a pulse oximetry device in the operating room and their oxygen saturation % (spO2) was recorded.

    Time frame: Immediately after induction of anesthesia

  9. Oxygen Saturation

    The patients were monitored with a pulse oximetry device in the operating room and their oxygen saturation % (spO2) was recorded.

    Time frame: 5 minutes and 10 minutes after direct laryngoscopy and endotracheal intubation

07

Study locations

1 site
  • Derince Training and Research Hospital
    Kocaeli, 41900, Turkey
08

References and documents

Publications

  • Baronia AK, Singh PK, Maheshwari A, Jain VK, Mittal P, Pant KC. Inhaled lidocaine for prevention of hemodynamic changes in laryngoscopy and intubation. J Neurosurg Anesthesiol. 1992 Jul;4(3):154-9. doi: 10.1097/00008506-199207000-00002. PubMed 15815458 ↗
  • Sklar BZ, Lurie S, Ezri T, Krichelli D, Savir I, Soroker D. Lidocaine inhalation attenuates the circulatory response to laryngoscopy and endotracheal intubation. J Clin Anesth. 1992 Sep-Oct;4(5):382-5. doi: 10.1016/0952-8180(92)90160-3. PubMed 1389192 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Dec 2023 to primary completion in Jun 2024, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2023
First posted
Oct 30, 2023
StartActual
Dec 1, 2023
Primary completionActual
Jun 1, 2024
CompletionActual
Jun 22, 2024
Last update
Jun 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06107543
Lead sponsor
Derince Training and Research Hospital
Responsible party
Emine Atlı (MD, Anesthesiology and Reanimation, Derince Training and Research Hospital) — Principal investigator
First posted
Oct 30, 2023
Start date
Dec 1, 2023
Primary completion
Jun 1, 2024
Completion
Jun 22, 2024
Last update
Jun 25, 2024

Oversight

Data monitoring committee
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion